Skip to Content

par 210 par 210 (Propafenone Extended Release 325 mg)

Pill imprint par 210 par 210 has been identified as Propafenone hydrochloride extended release 325 mg.

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substance Act (CSA).

Propafenone hydrochloride extended release 325 mg par 210 par 210
Discount Card Promo
Propafenone hydrochloride extended release
Imprint:
par 210 par 210
Strength:
325 mg
Color:
Orange & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Par Pharmaceutical Inc
National Drug Code (NDC):
49884-0210
Inactive Ingredients:
lactose anhydrous
magnesium stearate
povidone
FD&C Blue No. 1
gelatin
titanium dioxide
D&C Yellow No. 10
ferrosoferric oxide
butyl alcohol
propylene glycol
FD&C Blue No. 2
FD&C Red No. 40
shellac
alcohol
water
ethylcelluloses
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0917 Amerisource Health Services
42291-0546 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide